BridgeBio Pharma (BBIO) Asset Utilization Ratio (2021 - 2026)

BridgeBio Pharma (BBIO) has 6 years of Asset Utilization Ratio data on file, last reported at 0.5 in Q1 2026.

• For the quarter ending Q1 2026, Asset Utilization Ratio rose 255.33% year-over-year to 0.5; the trailing twelve-month figure through Mar 2026 stood at 0.5 (up 255.33% YoY), and the FY2025 full-year result was 0.54, up 78.74% from the prior year.
• Asset Utilization Ratio eased to 0.5 in Q1 2026, from 0.52 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.52 in Q4 2025 to a low of 0.01 in Q2 2023.
• A 5-year average of 0.2 and a median of 0.14 in 2025 frame the typical range for Asset Utilization Ratio.
• Across the five-year window, Asset Utilization Ratio plunged 90.41% in 2023 and soared 2552.92% in 2024, its largest moves.
• Tracing BBIO's Asset Utilization Ratio over 5 years: stood at 0.11 in 2022, then tumbled by 86.52% to 0.02 in 2023, then jumped by 1708.76% to 0.28 in 2024, then soared by 85.32% to 0.52 in 2025, then fell by 3.15% to 0.5 in 2026.
• Business Quant data shows BBIO's Asset Utilization Ratio at 0.5 in Q1 2026, 0.52 in Q4 2025, and 0.34 in Q3 2025.